Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBIT (2016 - 2025)

Stemtech's EBIT history spans 6 years, with the latest figure at -$339217.0 for Q3 2025.

  • On a quarterly basis, EBIT rose 52.65% to -$339217.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.8 million, a 52.89% increase, with the full-year FY2024 number at -$2.4 million, up 43.51% from a year prior.
  • EBIT hit -$339217.0 in Q3 2025 for Stemtech, down from -$300988.0 in the prior quarter.
  • Over the last five years, EBIT for STEK hit a ceiling of $33163.0 in Q4 2024 and a floor of -$3.4 million in Q3 2022.
  • Historically, EBIT has averaged -$788042.0 across 5 years, with a median of -$692309.0 in 2024.
  • Biggest five-year swings in EBIT: crashed 593.0% in 2023 and later soared 102.32% in 2024.
  • Tracing STEK's EBIT over 5 years: stood at -$104270.0 in 2021, then crashed by 314.54% to -$432237.0 in 2022, then crashed by 230.13% to -$1.4 million in 2023, then soared by 102.32% to $33163.0 in 2024, then tumbled by 1122.88% to -$339217.0 in 2025.
  • Business Quant data shows EBIT for STEK at -$339217.0 in Q3 2025, -$300988.0 in Q2 2025, and -$1.2 million in Q1 2025.